Apart from these, the enhanced activation of the CXCL12/CXCR4 axis in metastatic sites instituted an angiogenic switch and promoted prostate tumor metastasis that is mediated by a decreased expression of the glycolytic phosphoglycerate kinase 1 (PGK1) enzyme [206]. Here, CXCL12 is linked to prostate neoplasm.